Remove Blogging Remove Develop Remove Silver Lake Remove Venture Capital
article thumbnail

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

Xconomy

In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy, and more. You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69